Last updated: November 6, 2024
Sponsor: University Hospital Tuebingen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Melanoma
Treatment
N/AClinical Study ID
NCT06680323
834/2023BO2
Ages < 30 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
confirmed melanoma
age until 30 years old
Exclusion
Exclusion Criteria:
no available biological material
no signed informed consent
Study Design
Total Participants: 200
Study Start date:
January 01, 2024
Estimated Completion Date:
May 31, 2026
Study Description
Connect with a study center
Leibniz Research Institute for Environmental Medicine
Düsseldorf, 40225
GermanySite Not Available
University of Florence
Florence, 50121
ItalySite Not Available
Istituto Nazionale del Tumori
Milan, 20133
ItalySite Not Available
Medical University of Gdánsk
Gdańsk, 80-210
PolandActive - Recruiting
Hospital Clínic de Barcelona
Barcelona, 08036
SpainActive - Recruiting
Karolinska Institute
Solna, 17177
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.